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Abstract
Objective: This study examines obstetrician/gynecologists and family medicine physicians’ reported care patterns, attitudes
and beliefs and predictors of adherence to postpartum testing in women with a history of gestational diabetes mellitus.
Research Design and Methods: In November–December 2005, a mailed survey went to a random, cross-sectional sample of
683 Oregon licensed physicians in obstetrician/gynecologists and family medicine from a population of 2171.
Results: Routine postpartum glucose tolerance testing by both family physicians (19.3%) and obstetrician/gynecologists
physicians (35.3%) was reportedly low among the 285 respondents (42% response rate). Factors associated with high
adherence to postpartum testing included physician stated priority (OR 4.39, 95% CI: 1.69–7.94) and physician beliefs about
norms or typical testing practices (OR 3.66, 95% CI: 1.65–11.69). Specialty, sex of physician, years of practice, location, type of
practice, other attitudes and beliefs were not associated with postpartum glucose tolerance testing.
Conclusions: Postpartum glucose tolerance testing following a gestational diabetes mellitus pregnancy was not routinely
practiced by responders to this survey. Our findings indicate that physician knowledge, attitudes and beliefs may in part
explain suboptimal postpartum testing. Although guidelines for postpartum care are established, some physicians do not
prioritize these guidelines in practice and do not believe postpartum testing is the norm among their peers.
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Introduction
Gestational diabetes mellitus (GDM) is an important public
health concern as it increases the future risk of developing type 2
diabetes for both mother and child [1]. Defined as impaired
glucose tolerance first diagnosed during pregnancy, GDM affects
approximately 7% of pregnancies a year in the United States [2].
GDM is the most common metabolic complication of pregnancy
and its frequency reflects the frequency of type 2 diabetes the
underlying population [3].
A systematic review of GDM patients from 1965–2001 found
the cumulative incidence of type 2 diabetes increased markedly in
the first 5 years after a GDM pregnancy and appeared to plateau
after 10 years [4]. There is evidence that in some populations,
women with a history of GDM comprise a substantial proportion
of the type 2 diabetes population [5]. In a 2009 meta-analysis,
women with previous GDM had 7.5-times the risk of developing
type 2 diabetes in the future compared to women with
normoglycemic pregnancy [6].
There is evidence that lifestyle modification can prevent or
delay the development of type 2 diabetes in high-risk populations
[7–9]. Improving care to women with a history of GDM could
reduce the incidence of type 2 diabetes since women with a history
of GDM comprise a high-risk group, postpartum care and
continued follow-up care should be a priority. Therefore, the
US National Diabetes Education Program encourages obstetri-
cian/gynecologists (Ob/Gyns) and primary care providers to
better serve the needs of women with prior gestational diabetes
[10]. The puerperium period is frequently referred to as an
opportune time for a woman’s physician to encourage health
habits and provide medical therapy that ultimately may improve
her quality of life [11]. Physicians are uniquely situated to detect
diabetes, deliver care, and educate women with a history of GDM
during the prodromal period of disease.
There are inconsistent recommendations for postpartum testing
published by the American Diabetes Association (ADA) [12], the
American College of Obstetrics and Gynecologists (ACOG) [13],
the American Academy of Family Physicians [14], and the Fifth
International Workshop-Conference on Gestational Diabetes
Mellitus Panel [15]. The American Diabetes Association recom-
mends testing with either fasting plasma glucose (FPG) or an oral
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Dglucose tolerance test (OGTT) to reclassify maternal glycemic
status [12]. ACOG recommends testing by OGTT to identify a
greater number of women with impaired glucose tolerance [13].
The American Academy of Family Physicians recommends that
women have their glucose tested prior to discharge and that
‘‘regular testing for type 2 diabetes should be strongly encouraged’’
thereafter [14]. The opinion of the Fifth International Workshop
Panel is that women who do not have GDM in the immediate
postpartum period should be screened with OGTT 6 to 12 weeks
postpartum [15]. The panel considered FPG to be inadequate at
identifying women with impaired glucose tolerance [15]. To date,
follow-up care has been found to be inadequate in a number of
studies [16–20]; including the findings from a recent systematic
review which reported only half of women in most populations are
screened [21].
This study explores the extent to which physicians report
performing impaired glucose tolerance testing in the postpartum
period in one US state and explores physician characteristics,
knowledge, attitudes and beliefs that may elucidate the observed
sub-optimal follow-up care that has been previously reported.
Methods
This cross-sectional study assessed physician knowledge,
attitudes, beliefs and practice patterns regarding the care of
women with gestational diabetes. A representative sample of
Oregon physicians (MDs) holding active licenses with the Oregon
Board of Medical Examiners in Family Medicine (FM) and
Obstetrics/Gynecology (Ob/Gyn) received a survey at the end of
2005. The total population of MDs in these two specialties was
2171 (1614 FM and 557 Ob/Gyns). A disproportionate random
sample of 750 MDs was selected using Stata Intercooled (Version
9; College Station, Texas) with a larger proportion of Ob/Gyn
physicians sampled to adequately represent the specialty that most
often care for pregnant women. Three-hundred Ob/Gyn physi-
cians and 450 FM physicians were sent surveys using a three pass
method in which first a letter of explanation was sent with the
initial survey, second a reminder postcard, and third a new cover
letter and another copy of the survey over a three week period.
This project was approved by the Institutional Review Board at
Oregon State University.
The survey was designed to examine physician care patterns
both during pregnancy and in the postpartum period; the current
study focuses on only the postpartum period. Physicians responded
to statements regarding postpartum care knowledge following
GDM on a five-point likert-scale (never, rarely, some of the time,
most of the time, always) and additional statements reflecting their
attitudes and beliefs about glucose testing in the postpartum period
using a four-point likert-scale (strongly disagree, somewhat
disagree, somewhat agree, and strongly agree). Physicians also
responded to one question about the priority of postpartum
glucose testing on a four-point likert-scale (very low priority,
somewhat low priority, somewhat high priority, very high priority).
Likert-scale questions were further dichotomized for summary and
analyses in the following manner: five-point likert-scale items
never, rarely, sometimes to ‘‘no’’ while most of the time and
always were dichotomized to ‘‘yes’’ the four point likert-scale items
were dichotomized to ‘‘disagree’’ for strongly disagree and
somewhat disagree while somewhat agree and strongly agree were
dichotomized to ‘‘agree’’ and the four point likert-scale question
regarding priority was dichotomized in the same manner as high
and low. The survey questions were presented in a skip pattern
format so that if a physician did not work with pregnant women
they could skip to the questions regarding postpartum care.
Physicians identified their practice area as rural, urban, or
suburban based on their own perceptions rather than defined
population parameters. All variables included in the analyses were
self-reported including the physicians primary practice area.
Multivariate logistic regression was used to examine factors that
might explain differences in reported adherence to postpartum
glucose testing. All analyses were carried out using Stata 11.2,
College Station, Texas 77845 USA.
Results
A total of 285 of 683 eligible physicians participated in the
GDM care survey, representing a response rate of 42%. Forty-five
MDs did not participate because of inactive status or relocation.
Twenty-two physicians identified their primary practice specialty
as ‘‘other’’ and they were excluded from the analysis; of these 4
were licensed in FM and 18 in Ob/Gyn. FM physicians returned
166/383 completed surveys, a response rate of 44%, and Ob/Gyn
physicians returned 119/300 completed surveys, a response rate of
40%.
A summary of respondent demographic characteristics is shown
in Table 1. FM physicians were more likely to be male and rural
than Ob/Gyns. Ob/Gyn physicians were more likely to see
pregnant women. Of the 285 respondents, 192 worked with
pregnant women in their practice. Of the 93 respondents who did
not see women during pregnancy, only ten identified themselves as
Ob/Gyns.
Table 2 summarizes physician responses regarding the care
provided to GDM women dichotomized from a series of likert-
scale questions. Differences between specialties are examined using
the Chi-square test with associated p-values (table 2). Ob/Gyn
physicians were more likely to state that they routinely test for
glucose intolerance in the postpartum period and were more likely
to report they inform women that they are at increased risk for
type 2 diabetes. More FM physicians identified believing that
postpartum testing following GDM is a cost-effective primary
prevention of type 2 diabetes but the differences by specialty are
not statistically significant. When asked about the risk for
progressing to type 2 diabetes in the future, both FM and Ob/
Gyn physicians (73.5% and 69.8% respectively) identified agree-
ment that women are at high risk for progressing to type 2
diabetes. Physicians were also asked to identify agreement with
GDM being a transient metabolic condition. Thirty-six percent of
Ob/Gyn physicians agreed that GDM was transient while only
18.7% of FM physicians agreed with this statement. Both family
physicians and Ob/Gyns responded similarly regarding testing
norms but differences by specialty were found regarding priority in
practice.
Logistic regression results (table 3) indicate that adherence to
postpartum glucose testing is explained in part by two variables,
priority in practice and practice norms. Physicians that considered
postpartum glucose testing to be a priority (OR 4.39, 95% CI:
1.69–7.94) and those that believed testing to be typical or a
practice norm (OR 3.66, 95% CI: 1.65–11.69) were more likely to
indicate adhering to guidelines to reclassify glycemic status in the
postpartum period. Postpartum testing did not differ by physician
specialty, sex, years of practice, or type of medical practice.
Discussion
We found postpartum testing for women with a history of GDM
was not routinely practiced in this statewide sample. Although
guidelines for postpartum care are established, many physicians do
not prioritize these guidelines in practice and do not believe
postpartum testing is the norm among their peers. Our findings
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suboptimal postpartum testing while other physician characteris-
tics do not seem to influence practice patterns.
Although our study relies solely on self-reported physician
practice patterns, suboptimal postpartum glucose testing was
reported. Other studies examining postpartum testing have also
found suboptimal postpartum glucose testing. A systematic review
reported only half of women in most populations are screened [21]
Stasenko et al. reported a 33.7% follow-up in a US academic
center cohort [22]. In a recent study that included approximately
800,000 women, only 19% of women with GDM received
postpartum diabetes testing within a 6-month period [17]. Our
findings are similar to those of a survey conducted with family
medicine physicians in Texas in which 33% of respondents
reported providing follow-up care to a patient with GDM [22],
and those of Blatt et al. [17] which relied on a review of women
who used the services of Quest Diagnostics. A 2009 publication,
reported an increase in postpartum screening between 1995 and
2006 but screening was still suboptimal at 53% in a large cohort
from six translation research centers [20]. One surprising finding
of our study is that postpartum glucose testing was suboptimal
even though approximately 70% of physicians reported always
warning women about their increased risk for type 2 diabetes.
Potential explanations may include physicians do not believe that
they can delay the onset of type 2 diabetes, they may view another
health practitioner as responsible for the follow-up, or the patients
fail to return but physicians do understand that the patients are at
increased risk.
The practice type to which a woman is referred for postpartum
follow-up care may influence the likelihood of her receiving a
glucose tolerance test. Russell et al. reported that women attending
follow-up visits at a hospital-based clinic, as opposed to a hospital-
affiliated community clinic, were twice as likely to complete the
recommended postpartum glucose testing [16]. However, our
findings did not support practice type as a significant predictor of
reported postpartum glucose testing.
A lack of consensus regarding when to test, which test to
perform, and who is responsible may create a barrier to
postpartum testing. Although the American Diabetes Association
guidelines [12] recommend that glucose tolerance testing be
performed at a minimum of three year intervals, more recent
guidelines suggest annual testing, since women with a history of
GDM are most at risk of type 2 diabetes development in the first
10 years postpartum [23]. One study conducted in England found
primary and secondary care doctors disagreed about the tests and
responsibilities for follow-up [24]. Additionally, a recent study
examined the usefulness of Hemoglobin A1C, alone or combined
with a fasting glucose test, compared to an oral glucose tolerance
test for use in the postpartum period as a means of reclassify
women with a history of GDM [25]. This may suggest that there is
dissatisfaction with existing recommendations. However, the
authors did conclude that their results indicate the hemoglobin
A1C test alone or in combination with fasting glucose was not
sensitive or specific enough for diagnosis [25]. Further, it is
possible that physicians’ perceive factors such as affordability of
care, insufficient appointment time, inadequate reimbursement,
lack of resources and lack of support personnel as the barrier to
more frequent glucose tolerance testing. These factors have been
identified as barriers to the provision of quality diabetes care
among community health centers [26,27].
The influence of respected peers may also be a barrier.
Physicians may be aware of, understand and agree with clinical
practice guidelines, but their decision to adopt and act on new
information is often influenced by the perceived opinions of their
respected peers [28].The social influence theory describes how
factors such as custom and habit, assumptions and beliefs of peers,
prevailing practices and social norms define and shape the
interpretation of information obtained through educational means
[29]. The failure of physicians to adopt practice guidelines for the
postpartum care of GDM women may, in part, be explained by
this theory. When we assessed the beliefs and attitudes of
physicians, only 7% of respondents reported to ‘strongly agree’
that ‘most physicians provide follow-up glucose testing’. Therefore,
as per the social influence theory, physicians who believe that the
majority of their peers are not implementing postpartum practice
guidelines may consider follow-up practices to be against the social
norm and hence, adoption of testing behavior is low.
Additionally, postpartum women may have their own set of
barriers. Bennett et al. explored barriers and facilitators in a
qualitative study with 22 postpartum women [30]. Reported
barriers included having a baby with increased health needs,
personal and family adjustment, the stress of a new baby, demands
of a baby’s schedule, experiences with medical care and services,
dissatisfaction with care, and fear of receiving bad news at an
appointment. Canadian patients reported time pressure as the
most common reason for a lack of follow-up [31]. Facilitators
included the availability of child care, wanting a check-up to be
cleared for return to work, a connection to clinical and office staff,
Table 1. Demographics of study respondents by physician
specialty (N=285).
Family Medicine Obstetrics/Gynecology Total
# of Respondents 166 (58.0%) 119 (42.0%) 285
Sex
Male 92 (55.0%) 53 (44.5%) 145
Female 75 (45.0%) 65 (54.6%) 140
Location
Urban 54 (32.5%) 35 (29.4%) 89
Suburban 52 (31.3%) 68 (57.1%) 120
Rural 60 (36.1%) 16 (13.5%) 76
Years in practice
,2 13 (7.8%) 6 (5.0%) 19
2–5 32 (19.3%) 21 (17.7%) 53
.5–10 27 (16.3%) 25 (21.0%) 52
.10–20 54 (32.5%) 38 (31.9%) 92
.20 40 (24.1%) 29 (24.4%) 69
Pregnant patients
Yes 83 (49.7%) 109 (92%) 192
No 83(49.7%) 10 (8%) 93
Type of Practice
HMO 12 (7.2%) 19 (16.0%) 31
Private (solo or two) 37 (22.3%) 24 (20.2%) 61
Private group 48 (28.9%) 55 (46.2%) 103
Public health 6 (3.6%) 1 (0.8%) 7
Community clinic 26 (15.7%) 1 (0.8%) 27
Hospital based
University based
3 (1.8%) 7 (5.9%) 10
10 (6.0%) 7 (5.9%) 17
Other 24 (14.5%) 5 (4.2%) 29
doi:10.1371/journal.pone.0047052.t001
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dressed [30]. Additionally, 85% of patients surveyed in a
Canadian sample reported they perceived reminders as helpful
[31]. A qualitative assessment of perceived barriers among women
in Atlanta, Georgia found most women were unaware of their risk
for developing type 2 diabetes later [32]. This finding could
indicate that their future risk was not properly communicated or
that these women failed to understand. Further, a review of health
beliefs among women with previous gestational diabetes concluded
that women had low risk perceptions for future type 2 diabetes
mellitus [33]. This suggests either a lack of communication
between health providers and patients or a lack of patient
understanding. A study of beliefs about health and illness in a
Swedish population reported that women were informed by
healthcare professionals about gestational diabetes being transient
[34]. Healthcare professionals may be inadvertently creating
patient barriers by providing misinformation. We did not explore
facilitators and barriers from the patient perspective but acknowl-
edge that patient barriers partially explain suboptimal follow-up.
A number of recent studies have explored factors that might
increase screening [31,35–41]. Several of these studies have
focused on reminders in different formats [31,35–38]. A Canadian
study found postpartum postal reminders enhanced screening in
the postpartum period [31]. Lawrence et al. reported that
automated orders for follow-up testing in parallel with notifications
to physicians and electronically generated reminders to patients by
telephone and email may increase follow-up [36]. Another study
found a telephonic nurse management program was associated
with increased postpartum testing [37]. Further, the use of a letter
or phone call increased oral glucose tolerance testing from 14% to
28% within six months postpartum in another Canadian study
[38]. A US study reported educational counseling delivered by a
nurse educator in the antepartum period (37–38 weeks) increased
postpartum testing [35]. In addition to reminders and counseling,
improved communication between primary care and secondary
care are reportedly important [41]. Morrison et al report that a
team approach to managing care may reinforce the need for
postnatal diabetes testing [39] and Lapolla et al. reported that
Table 2. Physician knowledge of guidelines by specialty (N=285).
Survey statements Family Medicine Obstetrics/Gynecology Total p-value
166 (58.0%) 119 (42.0%) 285
If a woman had GDM, I routinely screen for glucose intolerance at her first postpartum visit
a p,0.001*
Yes 32 (19.3%) 42 (35.3%) 74
No 86 (51.8%) 71(59.7%) 157
Not applicable 48 (28.9%) 6 (5.0%) 54
I tell post-GDM women that they are at an increased risk for type 2 diabetes
a p,0.001*
Yes 32 (21.1%) 42 (36.2%) 74
No 86 (56.6%) 71 (61.2%) 157
Not applicable 48 (28.9%) 6 (5.0%) 54
Testing post GDM women annually is cost-effective primary prevention of type 2 diabetes
b p..05
Agree 103 (62.05%) 57 (47.9%) 160
Disagree 52 (31.3%) 51 (42.9%) 103
No response 11 (6.6%) 11 (9.2%) 22
Over 50% of women with GDM pregnancies will progress to type 2 diabetes within 10 years
b p..05
Agree 122 (73.5%) 83 (69.8%) 205
Disagree 31 (18.7%) 32 (26.9%) 63
No response 13 (7.8%) 4 (3.4%) 17
I feel that GDM is a transient metabolic condition of pregnancy
b p,.005*
Agree 31 (18.7%) 43 (36.1%) 74
Disagree 122 (73.5%) 72 (60.5%) 194
No response 13 (7.8%) 4 (3.4%) 17
Most physicians provide follow-up glucose testing after a GDM pregnancy
b p..05
Agree 64 (38.6%) 41 (34.5%) 105
Disagree 85 (51.2%) 70 (58.8%) 155
No response 17 (10.2%) 8 (6.7%) 25
To what extent is testing post GDM women a priority in your practice
c p,.05*
Low 96 (57.8%) 71 (59.7%) 167
High 55(33.13%) 46 (38.7%) 101
No response 15 (9.0%) 2 (1.7%) 17
a. 5 point likert-scale dichotomized (never, rarely, sometimes=no and most of the time and always=yes).
b. 4 point likert-scale dichotomized (strongly disagree, somewhat disagree=disagree and somewhat agree and strongly agree=agree).
c. 4 point likert-scale dichotomized (very low priority and somewhat low priority=low and somewhat high priority and very high priority=high).
*significant difference between FM and Ob/Gyn.
doi:10.1371/journal.pone.0047052.t002
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provider team are recommended [40].
Prevention measures are critical; women of reproductive age are
currently experiencing increases in the prevalence of chronic
diseases such as type 2 diabetes [42]. Future research should
explore mechanisms for removing physician barriers to providing
comprehensive postpartum care. For instance, a lack of awareness
or knowledge about a woman’s increased diabetes risk for type 2
diabetes after a GDM-affected pregnancy may contribute to
suboptimal postpartum testing. We found that 26% of physicians
surveyed believed that GDM is a transient metabolic condition of
pregnancy and are, therefore, unlikely to consider postpartum
glucose testing a priority. This is consistent with an earlier survey
study in which family practice physicians reported inadequate
knowledge concerning postpartum glucose testing and future risk
for type 2 diabetes following a pregnancy complicated by GDM
[22]. Another barrier may be confusion over postpartum practice
guidelines. A survey of Ohio practitioners reported use of 2-hr 75
gram OGTT, fasting blood sugar, other, home self-monitoring,
hemoglobin A1C, and random glucose among those that report
offering follow-up care [43]. The American Diabetes Association
[12], the American College of Obstetricians and Gynecologists
[13], the Fifth International Congress Workshop for Gestational
Diabetes [15], the International Diabetes Federation [23], and the
Canadian Diabetes Association [44] all recommend follow-up
glucose testing at approximately six weeks postpartum, although
the suggested method of testing, e.g., OGTT versus FPG, and the
required frequency of follow-up testing after the initial postpartum
visit varies. This may be causing confusion that leads to inactivity.
The fragmented medical system could also pose a barrier as
reported in a Canadian study [31]. In the US, a woman could be
diagnosed with GDM by an obstetrician or family medicine doctor
but then may be referred to an endocrinologist for care during the
pregnancy and then referred back to the primary care provider
after delivery. We suffer from the same fragmentation.
The main strength of this study is its investigation of practice
patterns, including knowledge, attitudes and beliefs, among a
random sample of physicians who are responsible for providing
postpartum care to women with a history of GDM. Our study
supports earlier evidence that poor clinical awareness of
gestational diabetes, methods of testing and local guidelines affect
the standard and consistency of care provided [45]. However, our
findings demonstrate that awareness of standards is insufficient;
the importance of physician prioritization and practice norms in
medical practice may be as important as other factors that
promote or inhibit follow-up testing.
This study has the following limitations. First, the response rate
is low but typical for physician surveys. Second, the study relies on
self-reported practice patterns and, therefore, all questions may
not have been answered truthfully, or responses could have been
influenced by social desirability bias. Third, all physicians surveyed
were based in a single US state and, therefore, the results may not
be reflective of physician practice patterns throughout the US.
Forth, the survey content may have limited the results as only
physicians were assessed and therefore, we could not consider the
influence of patient-related factors, organizational, structural,
philosophical and financial barriers that may have affected
postpartum glucose tolerance testing. Finally, data was collected
a number of years ago, but despite this limitation, our findings
seem to be supported by more recent studies which indicate testing
is suboptimal, health practitioners continue to inform their
patients that GDM is transient in some cases, and that postpartum
screening is still not a universal norm.
Postpartum glucose testing is low and this may be influenced by
priorities in practice and practice norms. Clear, non-conflicting
postpartum practice guidelines should be agreed upon and
adopted to aid in removing potential barriers. Clear messaging
to physicians would likely improve adherence to postpartum
follow-up testing. Physicians may need help in understanding their
role in the broader, public health system that aims to modify
health risks and promote women’s health.
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